Hobart, Australia

Southern Clinical Research Pty Ltd

Arthritis

Rheumatoid Arthritis

Psoriatic Arthritis

Filgotinib

Upadacitinib

ABT-494

Methotrexate

Adalimumab

Ixekizumab

AbbVie

Alfasigma

Lilly

Mesoblast

condition

allSponsorName

Gilead Sciences

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the parent studies of filgotinib in rheumatoid arthritis (RA).

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

Southern Clinical Research Pty Ltd | Hobart, Australia

Site insights

Work at this site?

Active trials

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis (FINCH 4)

Trial sponsors